Hanno Glimm
0000-0003-4104-1135
4 papers found
Refreshing results…
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers
High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma*
KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors — TORC1/2 Inhibition as Salvage Strategy
Missing publications? Search for publications with a matching author name.